| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.002 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.003 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.004 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.3 | 0.004 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |